Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 2
2006 3
2007 2
2008 2
2011 2
2015 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Validity of the autism diagnostic interview-revised.
Lecavalier L, Aman MG, Scahill L, McDougle CJ, McCracken JT, Vitiello B, Tierney E, Arnold LE, Ghuman JK, Loftin RL, Cronin P, Koenig K, Posey DJ, Martin A, Hollway J, Lee LS, Kau AS. Lecavalier L, et al. Am J Ment Retard. 2006 May;111(3):199-215. doi: 10.1352/0895-8017(2006)111[199:VOTADI]2.0.CO;2. Am J Ment Retard. 2006. PMID: 16597187
Acute and long-term safety and tolerability of risperidone in children with autism.
Aman MG, Arnold LE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Shah B, Gonzalez NM, Swiezy NB, Ritz L, Koenig K, McGough J, Ghuman JK, Lindsay RL. Aman MG, et al. J Child Adolesc Psychopharmacol. 2005 Dec;15(6):869-84. doi: 10.1089/cap.2005.15.869. J Child Adolesc Psychopharmacol. 2005. PMID: 16379507 Clinical Trial.
Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B. Aman M, et al. J Child Adolesc Psychopharmacol. 2015 Aug;25(6):482-93. doi: 10.1089/cap.2015.0005. J Child Adolesc Psychopharmacol. 2015. PMID: 26262903 Free PMC article. Clinical Trial.
Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.
Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L; RUPP ADHD/Anxiety Study Group. Abikoff H, et al. J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):418-27. doi: 10.1097/01.chi.0000155320.52322.37. J Am Acad Child Adolesc Psychiatry. 2005. PMID: 15843763 Clinical Trial.
Genome-wide association study of the child behavior checklist dysregulation profile.
Mick E, McGough J, Loo S, Doyle AE, Wozniak J, Wilens TE, Smalley S, McCracken J, Biederman J, Faraone SV. Mick E, et al. J Am Acad Child Adolesc Psychiatry. 2011 Aug;50(8):807-17.e8. doi: 10.1016/j.jaac.2011.05.001. Epub 2011 Jul 13. J Am Acad Child Adolesc Psychiatry. 2011. PMID: 21784300 Free PMC article.
Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.
Tobiasova Z, van der Lingen KH, Scahill L, Leckman JF, Zhang Y, Chae W, McCracken JT, McDougle CJ, Vitiello B, Tierney E, Aman MG, Arnold LE, Katsovich L, Hoekstra PJ, Volkmar F, Bothwell AL, Kawikova I. Tobiasova Z, et al. J Child Adolesc Psychopharmacol. 2011 Dec;21(6):555-64. doi: 10.1089/cap.2010.0134. Epub 2011 Nov 9. J Child Adolesc Psychopharmacol. 2011. PMID: 22070180 Free PMC article. Clinical Trial.
15 results